All In Biotech

Drug Trial Radar · NCT07573176

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate Efficacy and Safety of Seltorexant as Monotherapy in Adult and Elderly Participants With Major Depressive Disorder (MDD) and an Open-label Long-term Extension Treatment With Seltorexant

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Apr 30, 2026

Primary completion

Aug 24, 2028

Study completion May 3, 2029

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
May 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess how well the study drug (JNJ-42847922) works (efficacy) compared with placebo in improving depressive symptoms in participants with major depressive disorder (\[MDD\], a common mood disorder that causes a lasting feeling of sadness and a loss of interest in everyday activities) in double-blind treatment phase. Further, to evaluate long-term safety and tolerability of JNJ-42847922 in participants with MDD in the open label treatment phase.

Conditions

  • Depressive Disorder, Major

Interventions

  • SeltorexantDrug

    Seltorexant tablet will be administered orally.

  • PlaceboDrug

    Placebo tablet will be administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Double Blind (DB) Treatment Phase: Change from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score in Participants with Major Depressive Disorder with Moderate-to-Severe Insomnia Symptoms (MDDIS)Time frame: Baseline up to Day 43
  2. Open-Label (OL) Treatment Phase: Number of Participants with Adverse Events Including Adverse Event of Special Interests (AESIs)Time frame: OL Baseline (Day 43) Up to 6 months
  3. OL Treatment Phase: Number of Participants with Vital Signs AbnormalitiesTime frame: OL Baseline (Day 43) Up to 6 months
  4. OL Treatment Phase: Number of Participants with Suicidality Assessment using Columbia-Suicide Severity Rating Scale (C-SSRS)Time frame: OL Baseline (Day 43) Up to 6 months
  5. OL Treatment Phase: Number of Participants with Withdrawal Symptoms Assessment Using Physician Withdrawal Checklist (PWC-20)Time frame: End of Treatment/Early withdrawal to end of the Follow-up visit (up to 14 days)
  6. OL Treatment Phase: Number of Participants with Abnormalities in Electrocardiogram (ECG)Time frame: OL Baseline (Day 43) up to 6 months
  7. OL Treatment Phase: Number of Participants Reporting Sexual Functioning using Arizona Sexual Experiences Scale (ASEX)Time frame: Up to 6 months
  8. OL Treatment Phase: Change from Baseline in the Body WeightTime frame: OL Baseline (Day 43) up to 6 months
  9. OL Treatment Phase: Change from Baseline in the Body Mass Index (BMI)Time frame: OL Baseline (Day 43) up to 6 months
  10. OL Treatment Phase: Change from Baseline in the Waist CircumferenceTime frame: OL Baseline (Day 43) up to 6 months
  11. OL Treatment Phase: Number of Participants with Abnormalities in Clinical Laboratory ParametersTime frame: OL Baseline (Day 43) up to 6 months

Locations

53 sites in 7 countries. Site status is shown where the registry gives one.

  • SanRo Clinical Research Group LLC WCG Clinical Network

    Bryant, Arkansas · Recruiting

  • CI Trials

    Bellflower, California · Recruiting

  • Behavioral Research Specialists LLC

    Glendale, California · Recruiting

  • Excell Research Inc

    Oceanside, California · Recruiting

  • NRC Research Institute

    Orange, California · Recruiting

  • Cenexel

    Riverside, California · Recruiting

  • Sunwise Clinical Research

    Walnut Creek, California · Recruiting

  • UHC Research

    Doral, Florida · Recruiting

  • Reliable Clinical Research

    Hialeah, Florida · Recruiting

  • K2 Medical Research

    Maitland, Florida · Recruiting

  • Pharmax Research Clinic Inc

    Miami, Florida · Recruiting

  • Nuovida Research Center

    Miami, Florida · Recruiting

  • IPTB Clinical Research

    Tampa, Florida · Recruiting

  • Health Synergy Clinical Research

    West Palm Beach, Florida · Recruiting

  • Agile Clinical Research Trials, LLC

    Atlanta, Georgia · Recruiting

  • Accelerated Clinical Research Group LLC

    Snellville, Georgia · Recruiting

  • Chicago Research Center

    Chicago, Illinois · Recruiting

  • Pharmasite Research, Inc.

    Baltimore, Maryland · Recruiting

  • Adams Clinical Boston

    Boston, Massachusetts · Recruiting

  • Adams Clinical Watertown

    Watertown, Massachusetts · Recruiting

  • Integrative Clinical Trials LLC

    Brooklyn, Mississippi · Recruiting

  • SPRI Clinical Trials, LLC

    Brooklyn, Mississippi · Recruiting

  • Vector Clinical Trials

    Las Vegas, Nevada · Recruiting

  • CenExel Marlton NJ

    Marlton, New Jersey · Recruiting

  • Bioscience Research LLC

    Mount Kisco, New York · Recruiting

  • Fieve Clinical Research Inc

    New York, New York · Recruiting

  • Adams Clinical Harlem

    New York, New York · Recruiting

  • Manhattan Behavioral Medicine

    New York, New York · Recruiting

  • Magnolia Clinical Research LLC

    Cary, North Carolina · Recruiting

  • Patient Priority Clinical Sites LLC

    Cincinnati, Ohio · Recruiting

  • Conrad Clinical Research

    Edmond, Oklahoma · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • Future Search Trials of Dallas

    Dallas, Texas · Recruiting

  • Baylor College of Medicine

    Houston, Texas · Recruiting

  • DM Clinical Research

    Houston, Texas · Recruiting

  • Sooner Clinical Research

    Oklahoma, Texas · Recruiting

  • R and H Clinical Research

    Stafford, Texas · Recruiting

  • Alpine Research Organization

    Clinton, Utah · Recruiting

  • Northwest Clinical Research Center

    Bellevue, Washington · Recruiting

  • Iternova Consultorios en Salud Mental

    Córdoba, Argentina · Recruiting

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.